Spectrofluorometric analysis of propranolol and atenolol
Gajewska, M.; Glass, G.; Kostelecki, J.
Acta Poloniae Pharmaceutica 49(3): 1-4
1992
ISSN/ISBN: 0001-6837 PMID: 16092403 Document Number: 402244
The optimal conditions for spectrofluorimetric determination of propranolol and atenolol in substance and pharmaceutical preparations were determined. Simultaneous comparison with spectrophotometric method was performed.
Document emailed within 1 workday
Related Documents
Telatyńska-Smieszek, B.ła. 2002: Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension Annales Academiae Medicae Stetinensis 48: 367-380Webster, J.; Petrie, J.C.; Robb, O.J.; Witte, K.; Lovell, H.G. 1987: Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide Journal of Human Hypertension 1(2): 121-126
Gaafar, K.; Salama, S.; el Batran, S. 1994: Studies on the glycemic and lipidemic effect of atenolol and propranolol in normal and diabetic rats Arzneimittel-Forschung 44(4): 496-501
Frewin, D.B.; Penhall, R.K.; Leonello, P.P.; Clapp, R.J. 1980: Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol New Zealand Medical Journal 92(672): 389-390
Epstein, S.E.; LUbbe, W.F. 1977: Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension South African Medical Journal 52(22): 875-879
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Niedermayer, W.; Seiler, K.U.; Wassermann, O. 1978: Pharmacokinetics of antihypertensive drugs (atenolol, metoprolol, propranolol and clonidine) and their metabolites during intermittent haemodialysis in humans Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 15: 607-609
Smith, R.D.; Barrett, J.A.; Wolf, P.S.; Pruss, T.P. 1985: The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs British Journal of Clinical Practice. Suppl 42: 35-43
Gajewska, M.; Glass, G.; Slezak, D. 1992: Spectrofluorometric analysis of select 1,4-benzodiazepine derivatives Acta Poloniae Pharmaceutica 49(3): 5-9
Watson, R.R.; Moriguchi, S.; Jackson, J.C.; Werner, L.; Wilmore, J.H.; Freund, B.J. 1986: Modification of cellular immune functions in humans by endurance exercise training during beta-adrenergic blockade with atenolol or propranolol Medicine and Science in Sports and Exercise 18(1): 95-100
Cannella, G.; Picotti, G.B.; Giambelli, A.; Scolari, F.; Cesura, A.M.; Tosoni, S.; Maiorca, R. 1982: Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient Giornale Italiano di Cardiologia 12(12): 884-888
Batke, J. 1982: Spectrofluorometric analysis of the dissociation of oligomeric macromolecules: correction for the absorption of exciting and emitted light in a side-bottom type fluorometer Analytical Biochemistry 121(1): 123-128
Jaillon, P.; Hecklé, J.; Weissenburger, J.; Cheymol, G. 1980: Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 212(2): 347-353
Edwards, K.G.; Tweed, J.A.; Saul, P.A.; Wright, F.W. 1986: A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension Pharmatherapeutica 4(10): 637-641
Marcó, E.J.; Otero, F.; Dopico, A.M.; Ramírez, A.J.; Degrossi, O.; Sánchez, R.A. 1990: Analysis of left ventricular function by radionuclide ventriculogram in hypertensive patients treated with atenolol Medicina 50(6): 518-520
Palatini, P.; Pessina, A.C.; Semplicini, A.; Moramio, P.; Casiglia, E.; Dal Palù, C. 1980: Analysis of the variability of arterial pressure in patients with labile and stable hypertension and changes induced with atenolol Giornale Italiano di Cardiologia 10(3): 301-308
Murakami, E.; Shiosaka, S.; Tohyama, M. 1981: Does fluorescent analogue of propranolol, 9-amino-acridine-propranolol, binding sites really show the beta-adrenoreceptors? Cellular and Molecular Biology Including Cyto-Enzymology 27(2-3): 133-137
Albani, F.; Riva, R.; Baldrati, A.; Cortelli, P.; Perucca, E.; Procaccianti, G.; Baruzzi, A. 1984: Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose International Journal of Clinical Pharmacology Research 4(1): 19-23
Ongcharit, C.; Tungsanga, K. 1977: Propranolol and propranolol with thiazide in hypertensive Thai patients Journal of the Medical Association of Thailand 60(10): 465-469
Mohamed, M.E.; Tawakkol, M.S.; Aboul-Enein, H.Y. 1983: Spectrofluorometric determination of pindolol and its dosage form Journal - Association of Official Analytical Chemists 66(2): 273-275